A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab | Biomarker Research | Full Text

A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab | Biomarker Research | Full Text

A preliminary analysis of interleukin-1 ligands as potential predictive biomarkers of response to cetuximab

The epidermal growth factor receptor (EGFR) monoclonal IgG1 antibody cetuximab is approved for first-line treatment of recurrent and metastatic (R/M) HNSCC as a part of the standard of care EXTREME regimen (plati...

Authors:Madelyn Espinosa-Cotton, Elana J. Fertig, Laura P. Stabile, Autumn Gaither-Davis, Julie E. Bauman, Sandra Schmitz, Katherine N. Gibson-Corley, Yinwen Cheng, Isaac J. Jensen, Vladimir P. Badovinac, Douglas Laux and Andrean L. Simons

Citation:Biomarker Research 2019 7:14

Content type:Research

Published on: 16 July 2019

• ViewFull Text
 
• ViewPDF